TACC2-FGFR2 fusion was identified in 0.02% of AACR GENIE cases, in intrahepatic cholangiocarcinomas and adenocarcinomas of the gastrointestinal tract from the esophagus to the colon [21]. The gene discussed is TACC2; the disease is adenocarcinoma.